Crédit Industriel et Commercial’s Terns Pharmaceuticals TERN Stock Holding History

Crédit Industriel et Commercial’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-90,236	Closed	-$4.76M	–	404
2026 Q1	$4.76M	Buy	+90,236	New	+$3.71M	0.37%	75

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Crédit Industriel et Commercial's TERN Position: Q2 2026 in Review

Crédit Industriel et Commercial sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 90,236 shares — an estimated $4.76M sold.

Crédit Industriel et Commercial first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $4.76M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Crédit Industriel et Commercial reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Crédit Industriel et Commercial sold 90,236 Terns Pharmaceuticals shares in Q2 2026, an estimated $4.76M.
Crédit Industriel et Commercial first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Crédit Industriel et Commercial's Terns Pharmaceuticals position peaked at $4.76M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q2 2026, filed 24 Jul 2026.